HomeCompareSMEBF vs JNJ

SMEBF vs JNJ: Dividend Comparison 2026

SMEBF yields 5.63% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMEBF wins by $483.9K in total portfolio value
10 years
SMEBF
SMEBF
● Live price
5.63%
Share price
$0.56
Annual div
$0.03
5Y div CAGR
44.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$514.2K
Annual income
$276,115.16
Full SMEBF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SMEBF vs JNJ

📍 SMEBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMEBFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMEBF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMEBF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMEBF
Annual income on $10K today (after 15% tax)
$478.61/yr
After 10yr DRIP, annual income (after tax)
$234,697.89/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SMEBF beats the other by $230,711.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMEBF + JNJ for your $10,000?

SMEBF: 50%JNJ: 50%
100% JNJ50/50100% SMEBF
Portfolio after 10yr
$272.2K
Annual income
$140,402.28/yr
Blended yield
51.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SMEBF
No analyst data
Altman Z
2.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMEBF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMEBFJNJ
Forward yield5.63%2.13%
Annual dividend / share$0.03$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR44.8%28%
Portfolio after 10y$514.2K$30.3K
Annual income after 10y$276,115.16$4,689.40
Total dividends collected$466.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMEBF vs JNJ ($10,000, DRIP)

YearSMEBF PortfolioSMEBF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,515$815.33$10,592$272.30+$923.00SMEBF
2$13,592$1,270.55$11,289$357.73+$2.3KSMEBF
3$16,573$2,029.47$12,123$472.89+$4.5KSMEBF
4$21,082$3,348.76$13,141$629.86+$7.9KSMEBF
5$28,322$5,764.71$14,408$846.81+$13.9KSMEBF
6$40,785$10,480.51$16,021$1,151.60+$24.8KSMEBF
7$64,064$20,424.13$18,122$1,588.22+$45.9KSMEBF
8$111,964$43,415.18$20,930$2,228.20+$91.0KSMEBF
9$222,482$102,680.67$24,792$3,191.91+$197.7KSMEBF
10$514,171$276,115.16$30,274$4,689.40+$483.9KSMEBF

SMEBF vs JNJ: Complete Analysis 2026

SMEBFStock

Sime Darby Berhad, an investment holding company, operates in the industrial, motors, logistics, healthcare, and other businesses in Malaysia and internationally. The company manufactures, assembles, and sells generators, and agricultural and industrial machineries; markets, installs, rents, and services security products; markets and installs electronic and electro-mechanical equipment, instruments, and systems integration; sells, rents, and assembles Caterpillar equipment and spare parts; reconditions used equipment and machineries; supplies global positioning systems/digital work site positioning, and machine control products for heavy and highway construction applications; sells lift trucks and spare parts, and services other material handling equipment; imports and sells technical, nautical, and scientific instruments, as well as mechanical, electrical, and electronic equipment; and sells, hires, and services survey and marine equipment. It also provides heat exchangers, radiators, process equipment modules, filters, and separators; training and security services; and consultancy and other services for installation, operation, repair, and maintenance of industrial machines, equipment, and vehicles. In addition, the company manufactures, sells, and distributes passenger and light commercial vehicles, and spare parts; imports and distributes motor vehicles; offers vehicle rental services; and engages in general investment activities. Further, it provides port and warehousing services; tugboat pilot, container, property management, and childcare services; and owns and manages logistics parks. Additionally, the company operates hospitals; provides insurance and reinsurance brokerage, and advisory services; and sells Trimble technical solutions, as well as provides engineering, procurement, construction, installation, hook-up, and commissioning services related to oil and gas industry. Sime Darby Berhad was founded in 1910 and is based in Petaling Jaya, Malaysia.

Full SMEBF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SMEBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMEBF vs SCHDSMEBF vs JEPISMEBF vs OSMEBF vs KOSMEBF vs MAINSMEBF vs ABBVSMEBF vs MRKSMEBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.